Literature DB >> 21165991

Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors.

Mark P LeGolvan1, Murray Resnick.   

Abstract

Colorectal cancer is the second leading cause of cancer related death in the United States. The majority of these deaths are due to metastasis, with the liver easily accounting as the most common site of deposit. While there are multiple steps in the CRC hepatic metastatic cascade, this review attempts to summarize the different processes involved, focusing on the most recent discoveries, as well as the associated effects in relation to prognosis.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21165991     DOI: 10.1002/jso.21817

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  17 in total

1.  Safety analysis of the oncological outcome after vein-preserving surgery for colorectal liver metastases detached from the main hepatic veins.

Authors:  Federico Tomassini; Italo Bonadio; Peter Smeets; Karen De Paepe; Giammauro Berardi; Liesbeth Ferdinande; Stéphanie Laurent; Louis J Libbrecht; Karen Geboes; Roberto I Troisi
Journal:  Langenbecks Arch Surg       Date:  2015-08-12       Impact factor: 3.445

2.  Current topics in colorectal liver metastasis.

Authors:  Yoshiharu Sakai
Journal:  Int J Clin Oncol       Date:  2011-08-11       Impact factor: 3.402

3.  Biofunctionalized Hybrid Magnetic Gold Nanoparticles as Catalysts for Photothermal Ablation of Colorectal Liver Metastases.

Authors:  Sarah B White; Dong-Hyun Kim; Yang Guo; Weiguo Li; Yihe Yang; Jeane Chen; Venkateswara R Gogineni; Andrew C Larson
Journal:  Radiology       Date:  2017-07-13       Impact factor: 11.105

Review 4.  Meeting the biologic challenge of colorectal metastases.

Authors:  Harold J Wanebo; Mark LeGolvan; Philip B Paty; Sukamal Saha; Markus Zuber; Michael I D'Angelica; Nancey E Kemeny
Journal:  Clin Exp Metastasis       Date:  2012-10-10       Impact factor: 5.150

5.  Radiosurgery for liver metastases. A single institution experience.

Authors:  Beatriz Amendola; Marco Amendola; Jesús M Blanco; Naipy Perez; Xiaodong Wu
Journal:  Rep Pract Oncol Radiother       Date:  2016-12-21

Review 6.  Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer-Y90 and Chemoembolization.

Authors:  Alexandra H Fairchild; Sarah B White
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

7.  PI3K expression and PIK3CA mutations are related to colorectal cancer metastases.

Authors:  Yu-Fen Zhu; Bao-Hua Yu; Da-Li Li; Hong-Lin Ke; Xian-Zhi Guo; Xiu-Ying Xiao
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

8.  Combined Inhibition of p38MAPK and PIKfyve Synergistically Disrupts Autophagy to Selectively Target Cancer Cells.

Authors:  Constandina E O'Connell; Alex Vassilev
Journal:  Cancer Res       Date:  2021-03-08       Impact factor: 13.312

9.  Stereotactic radiation therapy for liver metastases: factors affecting local control and survival.

Authors:  Nicolaus Hj Andratschke; Carsten Nieder; Franz Heppt; Michael Molls; Frank Zimmermann
Journal:  Radiat Oncol       Date:  2015-03-20       Impact factor: 3.481

10.  Aggressive treatment of patients with metastatic colorectal cancer increases survival: a scandinavian single-center experience.

Authors:  Kristoffer Watten Brudvik; Simer Jit Bains; Lars Thomas Seeberg; Knut Jørgen Labori; Anne Waage; Kjetil Taskén; Einar Martin Aandahl; Bjørn Atle Bjørnbeth
Journal:  HPB Surg       Date:  2013-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.